Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185744 · ClinicalTrials.gov registry record · NA
Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer
A NA study of Breast Cancer and Carcinoma, Ductal, sponsored by Stanford University.
- Active
- Registry status
- NA
- Development phase
- 121
- Enrollment target
- 1
- Study location
NCT00185744: Active NA study of Breast Cancer and Carcinoma, Ductal, sponsored by Stanford University.
NCT00185744 is a NA study of Breast Cancer and Carcinoma, Ductal that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 121 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00185744, a NA study of Breast Cancer and Carcinoma, Ductal, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine whether an accelerated course of radiotherapy delivered to the lumpectomy cavity plus margin using IORT as a single dose, intracavitary brachytherapy with the MammoSite device over 5 days, partial breast 3-D CRT in 5 days, or stereotactic APBI over 4 days is a feasible and safe alternative to a six and a half week course of whole breast radiotherapy. The study will measure both short and long-term complications of radiation treatment, short and long-term breast cosmesis, local rates of in-breast cancer recurrence, regional recurrences, distant metastases, and overall survival.
Conditions Studied
Interventions
- PROCEDURE Lumpectomy
- RADIATION Intra-Operative Radiotherapy (IORT)
- RADIATION Whole Breast Radiotherapy
- RADIATION Intracavitary Brachytherapy
- RADIATION Accelerated External Beam 3-D Conformal Radiotherapy
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2002-09 |
| Est. Completion | 2029-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00185744
The ClinicalTrials.gov registry entry for NCT00185744 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which Lumpectomy is the first listed.
NCT00185744 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00185744 about?
NCT00185744 is a clinical study titled "Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer". To determine whether an accelerated course of radiotherapy delivered to the lumpectomy cavity plus margin using IORT as a single dose, intracavitary brachytherapy with the MammoSite device over 5 days, partial breast 3-D CRT in 5 days, or stereotactic APBI over 4 days is a feasible and safe alternat...
What is the current status of trial NCT00185744?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 121 participants. The study started on 2002-09. Estimated completion is 2029-03.
What conditions does trial NCT00185744 study?
This clinical trial studies the following conditions: Breast Cancer, Carcinoma, Ductal.
What interventions are being tested in trial NCT00185744?
The interventions under investigation include: Lumpectomy (PROCEDURE), Intra-Operative Radiotherapy (IORT) (RADIATION), Whole Breast Radiotherapy (RADIATION), Intracavitary Brachytherapy (RADIATION), Accelerated External Beam 3-D Conformal Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT00185744?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00185744 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.